Insider Selling: Hinge Health (NYSE:HNGE) Director Sells 1,250 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 1,250 shares of the stock in a transaction on Friday, November 21st. The shares were sold at an average price of $45.68, for a total transaction of $57,100.00. Following the transaction, the director owned 27,750 shares of the company’s stock, valued at $1,267,620. This trade represents a 4.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Hinge Health Stock Up 2.3%

Shares of Hinge Health stock traded up $1.08 during trading hours on Monday, reaching $47.07. The company’s stock had a trading volume of 1,715,754 shares, compared to its average volume of 1,186,414. The business’s 50 day simple moving average is $49.69. Hinge Health Inc. has a one year low of $33.42 and a one year high of $62.18.

Hinge Health (NYSE:HNGE) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $154.21 million during the quarter, compared to the consensus estimate of $142.44 million. The firm’s revenue for the quarter was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its board has initiated a stock repurchase plan on Wednesday, November 12th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to purchase up to 7.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have recently commented on HNGE shares. Evercore ISI lifted their target price on Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Morgan Stanley raised their price target on Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 23rd. Weiss Ratings reiterated a “sell (d)” rating on shares of Hinge Health in a research report on Wednesday, October 8th. Wall Street Zen raised shares of Hinge Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $71.00 price target (up from $70.00) on shares of Hinge Health in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $59.93.

Institutional Investors Weigh In On Hinge Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HNGE. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Hinge Health in the 3rd quarter valued at about $37,000. Montag A & Associates Inc. bought a new stake in shares of Hinge Health during the second quarter valued at approximately $41,000. SBI Securities Co. Ltd. purchased a new stake in shares of Hinge Health in the second quarter valued at approximately $48,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of Hinge Health in the third quarter valued at approximately $49,000. Finally, Jones Financial Companies Lllp grew its stake in Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after purchasing an additional 870 shares in the last quarter.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.